Analyst Price Targets — BTMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 16, 2026 12:14 pm | Les Sulewski | Truist Financial | $4.00 | $2.01 | TheFly | Biote price target lowered to $4 from $5 at Truist |
| March 12, 2026 1:29 pm | — | National Bank | $2.50 | $1.58 | StreetInsider | biote Corp. (BTMD) PT Lowered to $2.50 at TD Cowen |
| January 7, 2026 12:20 pm | — | Truist Financial | $5.00 | $2.54 | TheFly | Biote price target lowered to $5 from $6 at Truist |
| June 21, 2024 6:37 am | Gregory Fraser | Truist Financial | $9.00 | $7.23 | StreetInsider | Truist Securities Reiterates Buy Rating on biote Corp. (BTMD) |
| March 13, 2024 5:46 am | Kaumil Gajrawala | Jefferies | $8.24 | $6.09 | StreetInsider | biote Corp. (BTMD) PT Raised to $8.24 at Jefferies |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for BTMD

IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj is a nationally recognized physician executive, board-certified OB/GYN and reproductive geneticist with more than two decades of experience spanning clinical practice, healthcare quality, academic medicine,…

[url="]Biote[/url] (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' pa

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced that Bob Peterson, Chief Financial Officer and Chief Business Officer, has been named Interim Chief Executive Officer and Director, effective June 8, 2026. Bret Christensen is stepping down from his role as Chief…

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BTMD.
U.S. House Trading
No House trades found for BTMD.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
